Screening for prostate cancer, like mammography for breast cancer, has long been a subject of intense debate, with advocates insisting that it saves lives and detractors arguing that it leads to too much unnecessary treatment.
与使用乳腺摄影筛查乳腺癌一样,前列腺癌筛查长期以来也一直饱受争议,支持者们坚称它可以挽救生命,反对者则认为它会导致过多不必要的治疗。
The decrease in testing is almost certainly a result of a recommendation against screening made in 2017 by the United States Preventive Services Task Force. The task force, an independent panel of experts picked by the government, found that risks outweighed the benefits of routine blood tests for prostate-specific antigen, or PSA, a protein associated with prostate cancer.
几乎可以肯定,近期筛查测试的减少是2017年美国预防服务工作组(United States Preventive Services Task Force)提出建议反对筛查的结果。这一由政府挑选的独立专家小组发现,对前列腺特异性抗原(PSA,一种前列腺癌相关的蛋白质)进行常规验血检查的风险远远超过了其效益。
Because prostate cancer often grows slowly, the panel said, screening finds many tumors that might never have harmed the patient. But they are treated anyway. As a result, it concluded, testing saves few lives and leads too many men into unneeded surgery or radiation, which often leaves them impotent and incontinent.
【男性究竟该不该做前列腺癌筛查】相关文章:
★ 用餐时交出手机就能获赠免费披萨 这家店已送出50张大披萨!
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15